Previous Article | Next Article 
Applied and Environmental Microbiology, December 2000, p. 5241-5247, Vol. 66, No. 12
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of Bacillus Species
Used for Oral Bacteriotherapy and Bacterioprophylaxis of
Gastrointestinal Disorders
Ngo Thi
Hoa,1
Loredana
Baccigalupi,2
Ashley
Huxham,1
Andrei
Smertenko,1
Pham Hung
Van,3
Sergio
Ammendola,4
Ezio
Ricca,2 and
And Simon M.
Cutting1,*
School of Biological Sciences, Royal Holloway
University of London, Egham, Surrey TW20 0EX, United
Kingdom1; Section of Microbiology,
Department of General and Environmental Physiology, University
Federico II, 80134 Naples,2 and Bioprogress
S.p.A., Anagni (FR),4 Italy; and
Laboratory of Microbiology, Ho Chi Minh University of
Medicine and Pharmacy, Ho Chi Minh City,
Vietnam3
Received 16 June 2000/Accepted 6 September 2000
 |
ABSTRACT |
Bacillus subtilis spores are being used for oral
bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders
in both humans and animals. Since B. subtilis is an aerobic
saprophyte, how spores may benefit the gut microbiota is an intriguing
question, since other probiotics such as Lactobacillus spp.
which colonize the gut are anerobes. As a first step in understanding
the potential effects of ingesting spores, we have characterized five
commercial products. An extensive biochemical, physiological, and
phylogenetic analysis has revealed that four of these products are
mislabeled. Moreover, four of these products showed high levels of
antibiotic resistance.
 |
INTRODUCTION |
Probiotics, or "friendly
bacteria," are becoming increasingly available to the public as
beneficial functional foods that purport to promote specific health
benefits to consumers (2, 14, 18). In some countries
probiotics are available for oral bacteriotherapy and
bacterioprophylaxis of gastrointestinal disorders in humans. Often
these disorders, many of which lead to diarrhea, are a direct result of
antibiotic use, which produces an imbalance in the composition of the
normal intestinal microbial flora. In the livestock industry the use of
probiotics has potential as an alternative to antibiotics by
competitive exclusion of pathogenic microorganisms (19),
with some commercial products, such as Paciflor, already available.
Bacteria most commonly used as probiotics include the lactic acid
bacteria (e.g., lactobacilli, enterococci, streptococci, and
bifidobacteria). Experimental evidence now suggests that the ingestion
of substantial numbers of harmless bacteria does indeed provide a
beneficial effect to the enteric flora (18). Precisely how
this is achieved and whether the commercial claims are justified
remains a contentious issue, though (14).
In addition to the lactic acid bacteria, Bacillus species
are also sold as probiotics. These consist of preparations of bacterial spores, with the potential advantage that the spore can survive transit
through the stomach intact. Bacillus species are
substantially different from other probiotic bacteria, though, being
primarily aerobic saprophytes found in the soil. If indeed they have
any health benefit, then one obviously important question is how? Do
spores germinate and colonize the gut, do they competively exclude
colonization by potential pathogens, or does the dormant spore provide
some unique stimulus to the gut microbiota, such as enhanced local immunity?
In an earlier study we have shown that one major Bacillus
probiotic marketed in Europe contained spores of a taxonomically and
phylogenetically unrelated Bacillus species (4).
This was surprising, considering that in Europe probiotics must be
licensed to be used as a functional or novel food.
In this work we have examined and characterized five commercial
Bacillus spore probiotics as a first step in understanding the nature of spore probiotics.
 |
MATERIALS AND METHODS |
Bacterial strains.
Bacteria were recovered by suspension of
dried probiotic preparations in distilled water followed by dilution
and serial plating on Difco sporulation agar (11). The
commercial preparations and manufacturers were as follows: Lactipan
plus (Istituto Biochimico Italiano S.p.A., Milan, Italy),
Domuvar (Consorzio Farmaceutico e Biotecnologico Bioprogress a.r.i.,
Anagni-FR, Italy), Bactisubtil Marion Merrell S.A. Bourgoin-Jallieu,
France), Biosubtyl, (National Institute of Vaccines and Biological
Substances, Da Lat, Vietnam), and Subtyl (Pharmaceutical Factory 24, Ho
Chi Minh City, Vietnam). A validated Bacillus subtilis
strain, PY79 (20), a derivative of strain 168, was used as a
B. subtilis type strain.
Strain depositions.
All strains characterized in this work
have been deposited with the Bacillus Genetic Stock Centre
(BGSC), The Ohio State University, Columbus
(http://bacillus.biosci.ohio-state.edu/). (BGSC designated names are
given in Table 5.)
Biochemical tests.
The API 50 CH kit (BioMerieux),
comprising 49 unique biochemical tests appropriate for
Bacillus spp., was used for diagnosis as described in the
manufacturer's instructions. The complete test was performed five
times for each strain. Hydrolysis of starch was as described previously
(3). Growth at pH 10.1 was by the method of Horikoshi and
Teruhiko (7), using Na2CO3 to adjust the pH. Sporulation was induced by nutrient exhaustion using Difco sporulation medium and measurements of heat-resistant spores were made
as described previously (11).
Electron microscopy.
Suspensions of sporulating bacteria
(from 4-day-old plate cultures) were fixed in 3% glutaraldehyde plus
4% paraformaldehyde in 0.1, M PIPES
[piperazine-N,N'-bis(2-ethanesulfonic acid] buffer (pH
7.2) according to method 1 of Page et al. (12). Silver
sections of Spurr resin-embedded material were stained with uranyl
acetate followed by Reynolds lead stain and viewed on a Zeiss EM 109 transmission electron microscope.
Antibiotic testing.
Fresh plate cultures grown on
Luria-Bertani (LB) medium were used to make bacterial suspensions with
a density of approximately 0.5, adjusted using McFarland standards.
Mueller-Hinton plates (Merck; NCCLS standard) were seeded using swabs.
Antibiotic-inpregnated discs (6-mm diameter; Oxoid) were placed on the
seeded plates, and following 18 h of growth at 37°C, zones of
inhibition were measured. Those strains showing a zone of inhibition of
less than 12 mm in diameter were characterized further for the MIC of
antibiotic required to inhibit cell growth. MICs were determined using
cultures grown in Mueller-Hinton broth.
Phylogenetic analysis.
Two oligonucleotides were used to
amplify the entire 16S rRNA (P1 [5'-GCGGCGTGCCTAATACATGC]
anneals to nucleotides [nt] 40 to 59, and P2
[5'-CACCTTCCGATACGGCTACC] anneals to nt 1532 to 1513, of
B. subtilis rrnE). The 1,400-base PCR product was sequenced in its entirety using an automated sequencer and oligonucleotides P1,
P2, P3 (5'-ACGCCGCGTGAGTGATGAAG-3') (anneals to nt 404 to 423 of B. subtilis rrnE), and P4
(5'-CATCTCACGACACGAGC-3') (anneals to nt 1093 to 1076 of
B. subtilis rrnE). The genes for 16S rRNA were aligned using
the Clasl1W program (EMBL Outstation http://www2.ebi.ac.uk/clastlw/), and the alignment was used to construct phylogenetic trees with the
Phylip software package from the Pasteur Institute
(http://bioweb.pasteur.fr/seqanal/phylogeny/). The tree represents
similarities between the 16S rRNA genes.
Nucleotide sequence accession numbers.
The recovered 16S
rRNA gene sequences have been deposited in GenBank with the following
accession numbers: Domuvar, AJ277904; Lactipan plus,
AJ277905; Subtyl, AJ277906; Biosubtyl "Dalat," AJ277907;
Bactisubtil, AJ277908.
 |
RESULTS |
General characteristics of Bacillus probiotics.
Five commercial probiotic preparations were characterized: Domuvar and
Lactipan plus, originating from Italy; Bactisubtil, from
France; and Subtyl and Biosubtyl "Dalat," from Vietnam. Bactisubtil was labeled as Bacillus cereus, Lactipan plus was
labeled as Lactobacillus sporogenes, and the other three
were labeled as B. subtilis. All were found to consist of
homogenous populations. We examined growth of these bacteria as well as
B. subtilis strain PY79, which is a derivative of the 168 type strain, in LB medium (Fig. 1A). All grew efficiently with similar growth rates, with the exception of
Domuvar, which always produced a noticeable lag before exponential growth and which grew slower than the other strains. We found that
Domuvar was the only strain which could support growth at pH 10.1 (Table 1). We also examined growth
anerobically and found that Biosubtyl "Dalat" could grow
efficiently. B. subtilis will not normally grow anerobically
unless provided with glucose and nitrate as a terminal electron
acceptor (10), so this result makes it highly unlikely that
the species was B. subtilis. Similarly, the probiotic Subtyl
was unable to hydrolyze starch, showing that it was not a B. subtilis strain, for which the capacity to hydrolyze starch is a
diagnostic feature (15). Two probiotic strains, Bactisubtil
and Subtyl, produced strong hemolysis when grown on either sheep or
horse blood agar plates. Biosubtyl "Dalat" also produced weak
levels of hemolysis when grown on sheep blood agar. Hemolysins are not
generally associated with B. subtilis strains but are
produced in strains of B. cereus (15).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Growth of probiotic strains. Bacterial strains were
grown at 37°C in LB medium (A) or Difco sporulation medium (B). The
strains were B. subtilis PY79 ( ), Bactisubtil ( ),
Subtyl ( ), Biosubtyl "Dalat" ( ), Domuvar ( ), and Lactipan
plus ( ). OD595, optical density at 595 nm.
|
|
Spore formation.
We examined spore formation using B. subtilis strain PY79 as a control. When grown in Difco sporulation
medium, Domuvar again produced a lag phase and exhibited a lower growth
rate (Fig. 1B). We examined sporulating cultures at hour 18 of
development for spore shape and position and for heat resistance (Table
1 and Fig. 2). Domuvar produced a very
low percentage of spores and consisted primarily of long filamentous
cells which had not broken down by septation into smaller cells. These
spores appeared to be less resistant to higher temperatures, with a
100-fold reduction in viable spores at 75°C compared to 65°C (Table
1). Both Bactisubtil and Biosubtyl "Dalat" contained spores which
varied in shape, being either ellipsoidal or spherical. The Subtyl
strain appeared to sporulate very efficiently, and we found that
following heat treatment at either 65 or 75°C, a higher viable count
(CFU per milliliter) was produced than in the unheated cultures. This
apparent paradox can be explained only if the spores are not able to
germinate efficiently on nutrient agar plates, but when spores are
heated this treatment activates germination and so increases the viable counts. It is known that B. subtilis spores germinate more
efficiently when heat activated at 75°C (9), which would
support this explanation. We also observed that Subtyl cultures plated
on Difco sporulation agar plates always produced two colony types
(white and translucent) at a 50:50 ratio. The white colony (Whi) type
consisted almost entirely of mature released spores. In contrast, the
translucent (Trn) colony type contained only 50% released spores and
many long filamentous sporangial cells containing spores or no
spores at all. When the Whi and Trn colony types were propagated, the Whi strain again generated two colony types (Whi and Trn) on Difco sporulation agar, showing that the Whi phenotype was genetically unstable. When grown in liquid culture, the Whi substrain of Subtyl produced a distinctive white, hydrophilic aggregate.

View larger version (114K):
[in this window]
[in a new window]
|
FIG. 2.
Sporulation. Phase-contrast microscopy of cultures
grown in Difco sporulation medium examined at approximately 12 h
after the initiation of sporulation is shown. Clockwise from top left,
B. subtilis PY79, Lactipan plus, Subtyl,
Biosubtyl "Dalat," Bactisubtil, and Domuvar.
|
|
Examination of spores of each strain by electron microscopy
revealed an exosporium in mature spores of Domuvar, Bactisubtil,
and
Biosubtyl "Dalat" (Table
1). The exosporium is a poorly defined
structure which is often found loosely attached to the outer coat
layer
(
1,
16). Subtyl spores had a most unusual appearance
(Fig.
3) and did not stain well with uranyl
acetate. Subtyl spores
appeared, however, to contain an exosporial
layer which was shed
into the surrounding medium. This is shown in Fig.
3, and although
highly speculative, it is possible that this shedded
material
produces the aggregate observed in liquid growth.

View larger version (132K):
[in this window]
[in a new window]
|
FIG. 3.
Electron microscopy of a mature Subtyl spore. The
material shed from the spore is thought to have come from the
exosporial layer associated with the outer coat layer. Bar, 0.2 µm.
EX, exosporium; OC, outer coat.
|
|
Antibiotic resistance.
We examined the resistance of each of
the probiotic strains to a selection of antibiotics using the disc
diffusion test (Table 2). Those strains
which showed small zones of inhibition (less than 12 mm) were
considered resistant and evaluated further to establish the MIC.
Substantial levels of resistance to several antibiotics were
identified, as shown in Table 3. All
strains, including B. subtilis PY79, were found to have a
basal level of resistance to spectinomycin (30 to 60 µg/ml). Although
the results were inconclusive, we failed to identify any plasmids in
the antibiotic-resistant strains, suggesting that drug resistance may
be chromosome borne (data not shown).
Phylogenetic analysis and species identification.
Initial
examination of the probiotic strains showed substantial heterogeneity
and indicated that at least some were unlikely to be B. subtilis. As a first step, we used the API CH 50 test to identify
species. This test generates a species identification as a percent
probability, and the accuracy increases the more times the test is
repeated. Our results shown in Table 4
identified Lactipan plus as most likely to be B. subtilis and Subtyl, Bactisubtil, and Biosubtyl "Dalat" as
most likely to be B. cereus. Domuvar, though, proved to be
unrecognizable using this test.
To determine the relatedness the strains at the genetic level, we
sequenced the entire 16S rRNA gene from each strain. Our
analysis (Fig.
4) revealed that Lactipan
plus
was 99% identical
to
B. subtilis strain PY79 (GenBank
accession no.
AF142577).
Both Dalat and Bactisubtil were members of the
B. cereus subgroup.
Bactisubtil was 99% conserved with
Bacillus thuringiensis (
D16281)
and 98% identical to
Biosubtyl "Dalat," while Biosubtyl "Dalat"
was 98% identical
to
B. thuringiensis (
D16281). Domuvar was
found to be 95%
homologous with another probiotic strain, Enterogermina
(
AF142576).
Subtyl did not show strong homology with any
Bacillus species in GenBank.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 4.
Phylogenetic relationship of Bacillus
probiotic bacteria. The relatedness of commercial Bacillus
probiotics based on analysis of 16S rRNA is shown. Enterogermina and
Biosubtyl (Biosubtyl "Nha Trang") are commercial
Bacillus probiotics and have been characterized elsewhere
(4).
|
|
 |
DISCUSSION |
The purpose of this study was to establish the identity of
Bacillus bacteria available in commercial spore probiotics
used for human consumption. In turn, this would provide an important and necessary first step in understanding how bacterial endospores might serve as "friendly bacteria" or probiotics. Our results were
somewhat unexpected and have proven intriguing, with only one
commercial product correctly labeled. For those products marketed or
produced in Europe this is of particular concern, since, as a novel
food, probiotics must be licensed and satisfy European Union
regulations (e.g., EC Regulation 258/97).
We have used both 16S rRNA analysis and biochemical tests to establish
species identity. Our final conclusions are shown in Tables 4 and
5. Lactipan plus is clearly
B. subtilis and is closely related to PY79. Strain PY79,
derived from the 168 type strain, is used extensively as an isogenic
strain for the genetic analysis of spore development (20).
What is surprising with this commercial product is that it is labeled
as Lactobacillus sporogenes. Neither Bergey's
Manual nor the Approved List of Bacterial Names cites
this as a species.
Domuvar was found in this work to tolerate growth at high pH. This was
a distinguishing feature of this strain, and we have observed this
previously with another commercial probiotic, Enterogermina (4). 16S rRNA analysis revealed Domuvar to be homologous
with Enterogermina, suggesting a common origin. Enterogermina has since been shown to be most closely related to Bacillus clausii
(17), and our sequence analysis also confirmed Domuvar to be
most closely related to this species. Enterogermina is a mixture of
three antibiotic-resistant derivatives, giving resistance to
chloramphenicol (strain O/C), novobiocin and rifampin (strain N/R), and
streptomycin and neomycin (strain SIN). All derivatives also have
chromosome-borne resistance to penicillin G, erythromycin, and
lincomycin. Domuvar was found to be resistant to novobiocin and
chloramphenicol as well as penicillin G, erythromycin, and lincomycin,
suggesting that it may have been derived from one of the Enterogermina
strains. Although it is highly probable that Domuvar and Enterogermina
have the same origin, it is curious that the sequences are not more
conserved. Both strains have been subject to a history of mutagenesis
in the process of creating antibiotic resistances, and this may, in
part, account for the sequence variation.
The Vietnamese probiotic Biosubtyl "Dalat" was found to be highly
conserved with the French probiotic Bactisubtil. Bactisubtil is
labelled as B. cereus strain IP 5832, and our analysis would confirm this if based only on biochemical data, notably, the production of hemolysins and an exosporium which are characteristic of B. cereus strains. Based on 16S rRNA analysis, though, this strain was clearly most similar to B. thuringiensis. B. thuringiensis strains nearly always produce parasporal crystal
toxins, and we were unable to identify such structures by microscopy.
We conclude, then, that this strain is most probably correctly labeled
as B. cereus. Interestingly this product, which is the same
as that found in the livestock probiotic Paciflor, was originally
labeled as B. subtilis (8). The Vietnamese
probiotic Biosubtyl "Dalat," produced at the Pasteur Institute in
Vietnam, was found to be virtually identical to Bactisubtil both at the
genetic level and using the API test. Although the similarity of these
strains suggests a common origin, there were some notable differences.
First, Biosubtyl "Dalat" grew reasonably well under anerobic
conditions, which is found in some B. cereus strains. A
second difference was in the antibiotic resistance profile. Biosubtyl
"Dalat" could grow at high concentrations of ampicillin and
penicillin G. In contrast, Bactisubtil was resistant to both
chloramphenicol and tetracycline. B. cereus strains are
known to contain a chromosomal
-lactamase (13), although
we are unable to comment on whether any drug resistance is plasmid encoded.
The last probiotic we examined was Subtyl. 16S rRNA analysis of this
strain did not show any significant homology with any known
Bacillus species, and in fact, it was so divergent that it
should be considered a new species. It was related to B. cereus based on biochemical tests, although at the genetic and
biochemical levels this species was the most diverged from existing
Bacillus species. We believe it should be considered a new
species, and we propose the name Bacillus vietnami. Another
feature of note with this strain was the high level of resistance to
penicillin and ampicillin. It is curious that both Vietnamese
probiotics should exhibit such high levels of resistance to these
antibiotics, and it is worrying that in southeast Asia, where the
overuse of antibiotics is widespread, ampicillin and
penicillin-resistant bacteria are being consumed on a daily basis.
In conclusion, although our original goal of characterizing spore
probiotics has been achieved, we have also revealed the poor state of
species classification being applied in the licensing of products for
human consumption (Table 5). In a previous study we found two other
probiotics to be mislabeled (4), and, as has been stressed
previously, this should be considered a public health issue (5,
6). The fact that some of these species have high levels of drug
resistance is of particular concern. It is not clear to us how spores
may exert a beneficial effect for oral bacteriotherapy. Only one
strain, Biosubtyl "Dalat," was found to support anerobic growth, so
in principle spores of this strain could germinate and colonize the
intestine as has been suggested previously (8). However, the
fact that the other strains were aerobic suggests another mechanism for
their action.
 |
ACKNOWLEDGMENTS |
We thank the Electron Microscopy Unit at the Royal Holloway
University of London for assistance with electron microscopy.
This work was supported by grants from the EU IVth framework (to S.M.C.
and E.R.), The Wellcome Trust (to S.M.C.), and Progetto Finalizzato
Biotecnologie-CNR (to E.R.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: School of
Biological Sciences, Royal Holloway University of London, Egham,
Surrey, TW20 0EX, UK. Tel: 01784-443760; Fax: 01784-434326; E-mail:
s.cutting{at}rhbnc.ac.uk.
 |
REFERENCES |
| 1.
|
Aronson, A. I., and P. Fitz-James.
1976.
Structure and morphogenesis of the bacterial spore coat.
Bacteriol. Rev.
40:360-402[Free Full Text].
|
| 2.
|
Atlas, R. M.
1999.
Probiotics snake oil for the new millenium?
Environ. Microbiol.
1:375-382[CrossRef][Medline].
|
| 3.
|
Cutting, S. M., and P. B. Vander-Horn.
1990.
Genetic analysis, p. 27-74.
In
C. R. Harwood, and S. M. Cutting (ed.), Molecular biological methods for Bacillus. John Wiley & Sons Ltd., Chichester, England.
|
| 4.
|
Green, D. H.,
P. R. Wakeley,
A. Page,
A. Barnes,
L. Baccigalupi,
E. Ricca, and S. M. Cutting.
1999.
Characterization of two Bacillus probiotics.
Appl. Environ. Microbiol.
65:4288-4291[Abstract/Free Full Text].
|
| 5.
|
Hamilton-Miller, J. M. T., and G. R. Gibson.
1999.
Efficacy studies of probiotics: a call for guidelines.
Br. J. Nutr.
82:73-75[Medline].
|
| 6.
|
Hamilton-Miller, J. M. T.,
S. Shah, and J. T. Winkler.
1999.
Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms.
Public Health Nutr.
2:223-229[Medline].
|
| 7.
|
Horikoshi, K., and A. Teruhiko.
1982.
Alkalophilic microorganisms.
Japan Scientific Societies Press, New York, N.Y.
|
| 8.
|
Mazza, P.
1994.
The use of Bacillus subtilis as an antidiarrhoeal microorganism.
Boll. Chim. Farmaceutico
133:3-18.
|
| 9.
|
Moir, A., and D. A. Smith.
1990.
The genetics of bacterial spore germination.
Annu. Rev. Microbiol.
44:531-553[CrossRef][Medline].
|
| 10.
|
Nakano, M. M., and P. Zuber.
1998.
Anaerobic growth of a "strict aerobe" (Bacillus subtilis).
Annu. Rev. Microbiol.
52:165-190[CrossRef][Medline].
|
| 11.
|
Nicholson, W. L., and P. Setlow.
1990.
Sporulation, germination and outgrowth, p. 391-450.
In
C. R. Harwood, and S. M. Cutting (ed.), Molecular biological methods for Bacillus. John Wiley & Sons Ltd., Chichester, United Kingdom.
|
| 12.
|
Page, A. M.,
J. R. Lagnado,
T. W. Ford, and G. Place.
1994.
Calcium alginate encapsulation of small specimens for transmission electron microscopy.
J. Micros.
175:166-170.
|
| 13.
|
Priest, F. G.
1993.
Systematics and ecology of Bacillus, p. 3-16.
In
A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria. American Society for Microbiology, Washington, D.C.
|
| 14.
|
Rowland, I.
1999.
Probiotics and benefits to human health the evidence in favour.
Environ. Microbiol.
1:375-382.
|
| 15.
|
Sneath, P. H. A.
1986.
Endospore-forming gram-positive rods and cocci, p. 1104-1207.
In
P. H. A. Sneath, N. S. Mair, M. E. Sharpe, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 2. Williams & Wilkins, Baltimore, Md.
|
| 16.
|
Sousa, J. C. F.,
M. T. Silva, and G. Balassa.
1976.
An exosporium-like outer layer in Bacillus subtilis spores.
Nature
263:53-54[CrossRef][Medline].
|
| 17.
|
Spinosa, M. R.,
T. Braccini,
E. Ricca,
M. De Felice,
L. Morelli,
G. Pozzi, and M. R. Oggioni.
2000.
On the fate of ingested Bacillus spores.
Res. Microbiol.
151:361-368[Medline].
|
| 18.
|
Tannock, G. W.
1999.
Probiotics: a critical review.
Horizon Scientific Press, Norfolk, United Kingdom.
|
| 19.
|
Tournot, J.
1989.
Applications of probiotics to animal husbandry.
Rev. Sci. Tech. Off. Int. Epiz.
8:551-566.
|
| 20.
|
Youngman, P.,
J. Perkins, and R. Losick.
1984.
Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene.
Plasmid
12:1-9[CrossRef][Medline].
|
Applied and Environmental Microbiology, December 2000, p. 5241-5247, Vol. 66, No. 12
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cartman, S. T., La Ragione, R. M., Woodward, M. J.
(2008). Bacillus subtilis Spores Germinate in the Chicken Gastrointestinal Tract. Appl. Environ. Microbiol.
74: 5254-5258
[Abstract]
[Full Text]
-
Girlich, D., Leclercq, R., Naas, T., Nordmann, P.
(2007). Molecular and Biochemical Characterization of the Chromosome-Encoded Class A {beta}-Lactamase BCL-1 from Bacillus clausii. Antimicrob. Agents Chemother.
51: 4009-4014
[Abstract]
[Full Text]
-
Tam, N. K. M., Uyen, N. Q., Hong, H. A., Duc, L. H., Hoa, T. T., Serra, C. R., Henriques, A. O., Cutting, S. M.
(2006). The Intestinal Life Cycle of Bacillus subtilis and Close Relatives.. J. Bacteriol.
188: 2692-2700
[Abstract]
[Full Text]
-
Teo, A. Y.-L., Tan, H.-M.
(2006). Effect of Bacillus subtilis PB6 (CloSTAT) on Broilers Infected with a Pathogenic Strain of Escherichia coli. J. Appl. Poult. Res.
15: 229-235
[Abstract]
[Full Text]
-
Teo, A. Y.-L., Tan, H.-M.
(2005). Inhibition of Clostridium perfringens by a Novel Strain of Bacillus subtilis Isolated from the Gastrointestinal Tracts of Healthy Chickens. Appl. Environ. Microbiol.
71: 4185-4190
[Abstract]
[Full Text]
-
Barbosa, T. M., Serra, C. R., La Ragione, R. M., Woodward, M. J., Henriques, A. O.
(2005). Screening for Bacillus Isolates in the Broiler Gastrointestinal Tract. Appl. Environ. Microbiol.
71: 968-978
[Abstract]
[Full Text]
-
Duc, L. H., Hong, H. A., Barbosa, T. M., Henriques, A. O., Cutting, S. M.
(2004). Characterization of Bacillus Probiotics Available for Human Use. Appl. Environ. Microbiol.
70: 2161-2171
[Abstract]
[Full Text]
-
Isticato, R., Cangiano, G., Tran, H. T., Ciabattini, A., Medaglini, D., Oggioni, M. R., De Felice, M., Pozzi, G., Ricca, E.
(2001). Surface Display of Recombinant Proteins on Bacillus subtilis Spores. J. Bacteriol.
183: 6294-6301
[Abstract]
[Full Text]
-
Hoa, T. T., Duc, L. H., Isticato, R., Baccigalupi, L., Ricca, E., Van, P. H., Cutting, S. M.
(2001). Fate and Dissemination of Bacillus subtilis Spores in a Murine Model. Appl. Environ. Microbiol.
67: 3819-3823
[Abstract]
[Full Text]